Period of time： 2003年4期
Publisher： Elsevier
Founded in： 1983
Total resources： 45
ISSN： 1078-1439
Subject： R73 Oncology
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Urologic Oncology: Seminars and Original Investigations,volume 21,issue 4
Menu
Access to resources
Recommend
A model for 3-dimensional growth of bladder cancers to investigate cell-matrix interactions
By Kyker K.D., Culkin D.J., Hurst R.E. in (2003)
Urologic Oncology: Seminars and Original Investigations,volume 21,issue 4 , Vol. 21, Iss. 4, 2003-07 , pp.CYP17 gene promoter allelic variant is not associated with prostate cancer
By Lin C.-C., Wu H.-C., Chen W.-C., Chen H.-Y., Tsai F.-J. in (2003)
Urologic Oncology: Seminars and Original Investigations,volume 21,issue 4 , Vol. 21, Iss. 4, 2003-07 , pp.By Gee J.R., Montoya R.G., Khaled H.M., Sabichi A.L., Grossman H.B. in (2003)
Urologic Oncology: Seminars and Original Investigations,volume 21,issue 4 , Vol. 21, Iss. 4, 2003-07 , pp.Seminars in urologic oncology: editorial overview
By Resnick M.I., Oefelein M.G. in (2003)
Urologic Oncology: Seminars and Original Investigations,volume 21,issue 4 , Vol. 21, Iss. 4, 2003-07 , pp.The truth is out there: an overall perspective on androgen deprivation
By Hellerstedt B.A., Pienta K.J. in (2003)
Urologic Oncology: Seminars and Original Investigations,volume 21,issue 4 , Vol. 21, Iss. 4, 2003-07 , pp.By Cho D., Di Blasio C.J., Rhee A.C., Kattan M.W. in (2003)
Urologic Oncology: Seminars and Original Investigations,volume 21,issue 4 , Vol. 21, Iss. 4, 2003-07 , pp.Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial
By Pollack A., Zagars G.K., Starkschall G., Antolak J.A., Lee J.J., Huang E., von Eschenbach A.C., Kuban D.A., Rosen I., Ritter M.A. in (2003)
Urologic Oncology: Seminars and Original Investigations,volume 21,issue 4 , Vol. 21, Iss. 4, 2003-07 , pp.
Previous
Next